Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Tfct-Nib Tablet

Prescription Icon
Prescription Required

Marketer

Ipca Laboratories Ltd

Salt Composition

Tofacitinib (5mg)

Overview Tfct-Nib Tablet

Nibifect tablets are indicated for moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. They alleviate joint pain, tenderness, and swelling by suppressing inflammation, and help retard the progression of bone and joint deterioration. Nibifect may be administered alone or in conjunction with other medications. The tablets can be taken with or without food, ideally at the same time daily. Dosage is determined by your condition and other medications. Always adhere to your physician's instructions; discontinue use only under their guidance, as abrupt cessation may exacerbate your condition. Common side effects include upper respiratory infections, headache, diarrhea, and nasopharyngitis. Less frequent, but potentially serious, adverse events like blood clots and gastrointestinal perforation require immediate medical attention. Discuss any concerns regarding side effects with your doctor. Pre-treatment blood work may be necessary, and the medication should not be initiated if you have an infection. Prior to commencing treatment, disclose any history of tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or pulmonary or venous thromboembolism. Nibifect increases susceptibility to infections and may worsen existing ones; minimize contact with contagious individuals (e.g., those with chickenpox, measles, influenza). This medication is contraindicated in patients under 18 years of age and during pregnancy or breastfeeding unless deemed beneficial by your physician. Regular monitoring by your doctor may be required.

Uses of Tfct-Nib Tablet

Management of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.

Major Benefits of Tfct-Nib Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Tfct-Nib Tablet whole; do not chew, crush, or divide it. While you may consume it with or without food, consistent timing is recommended.

Common Side effects of Tfct-Nib Tablet:

  • Upper respiratory tract infection
  • Headache
  • Diarrhea
  • Nasopharyngitis (inflammation of the throat and nasal passages)

How to use Tfct-Nib Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tfct-Nib Tablets can be administered with or without food, although consistent timing is recommended.

How Tfct-Nib Tablet works:

Tfcnibu tablets function as a Janus kinase inhibitor, suppressing Janus kinase enzyme activity. This reduces immune system activation and inflammation characteristic of rheumatic conditions and ulcerative colitis.

SAFETY ADVICE

AlcoholAlcoholSAFE

Alcohol consumption alongside Tfct-Nib tablets poses no known adverse reactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Tfct-Nib tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the benefits against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Tfct-Nib Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Tfct-Nib Tablet.

KidneyKidneyCAUTION

Patients with severe kidney impairment should use Tfct-Nib Tablets cautiously, as dose modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Individuals with significant hepatic impairment should exercise caution when using Tfct-Nib Tablets. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Tfct-Nib Tablet :

Should you forget a Tfct-Nib Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tfct-Nib Tablet

LabelValue
Chemical Category Pyrrolopyrimidine compound
Developing Habits No.
Treatment Category Pain Relievers
Action Class JAK inhibitors

FAQs on Tfct-Nib Tablet

Tell your doctor about any liver problems before taking Tfct-Nib Tablet. This is because it can sometimes raise liver enzyme levels, so your liver function should be checked beforehand. Tfct-Nib Tablet may be used in patients with mild to moderate liver impairment, but it's contraindicated in those with severe impairment.
Taking Tfct-Nib Tablet might raise your risk of certain cancers, such as lymphoma and skin cancer, due to its effects on the immune system. Tell your doctor if you have or have ever had cancer.
Tfct-Nib Tablets are indicated for moderate to severe rheumatoid arthritis, a joint inflammatory disease. This treatment is used when prior therapies proved ineffective or unsuitable. It may also be used earlier if initial medications are unsuccessful, and can be administered alone or in conjunction with other drugs, like methotrexate.
You may begin to feel improvement from Tfct-Nib Tablet within 2 to 8 weeks, with peak effects typically observed after 3 to 6 months.
Before and during treatment with Tfct-Nib Tablet, blood tests may be necessary. These tests check for anemia, neutropenia or lymphopenia, high cholesterol, and elevated liver enzymes, helping to monitor for treatment-related issues. Your doctor might also recommend a tuberculosis test beforehand, as Tfct-Nib Tablet could exacerbate an existing infection.
Tfct-Nib Tablet impacts your immune system, potentially lowering your resistance to infection and raising your risk of serious infections, such as tuberculosis. These infections could include severe fungal, bacterial, or viral infections spreading throughout the body, potentially life-threatening. Hospital treatment is recommended for such infections.
Taking tocilizumab and Tfct-Nib Tablet together is not recommended. Tfct-Nib Tablet's effect on the immune system means it shouldn't be combined with other immunosuppressants. Concurrent use increases infection risk and potential complications.
Tfct-Nib Tablet
418
MRP 484
13% off